Evotec holds the 200-day line, shares at a technical crossroads
24.06.2026 - 07:54:46 | ad-hoc-news.de
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-24, 07:51.
Evotec (DE0005664809) trades near a narrow chart band on Wednesday morning. TradingKey places support at 2.43 dollars and resistance at 2.95 dollars, while the current signal reads Sell. TradingKey technical view
The chart setup
TradingKey says Evotec's price momentum score stands at 6.17, with the stock ranked 291st out of 389 names in the Biotechnology & Medical Research industry. The same page lists 1 buy signal and 5 sell signals across moving averages.
That setup gives the shares a clearly defined band for Wednesday's session. The 200-day line is not cited on the page, but the moving-average mix is tilted toward weakness rather than strength.
Peer and sector frame
In the broader European biotech and research space, chart-driven trading remains sensitive to liquidity and to small changes in sentiment. Evotec's quote sits alongside a wider market diary that includes Germany and Europe updates on Tradegate this morning. Tradegate market news
That matters for a mid-cap name such as Evotec because technical levels can dominate the short-term conversation when investors trade around a defined range. The current report from TradingKey uses dollars, not euros, which points to an international data feed rather than a German venue quote.
All news and analysis on the Evotec shares
Follow the latest chart signals, company news and market commentary around Evotec in one place.
The business behind the stock
Evotec develops small-molecule drug discovery and laboratory services for pharmaceutical partners. The company also works across preclinical research and platform-based collaboration models.
Evotec shares today
The Evotec shares (DE0005664809) trade on 2026-06-24, 07:51 on Xetra at 2.62 euros.
Evotec at a glance
- Company: Evotec SE
- ISIN: DE0005664809
- Ticker: EVT
- Trading venue: Xetra
- Price (as of 2026-06-24, 07:51): 2.62 EUR
- Market cap: 929.89M USD (as of 2026-06-23)
- Sector / industry: Biotechnology & Medical Research
- Next earnings date: not officially scheduled
This article is for information only and does not constitute investment advice.
